MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
Open Access
- 1 December 2004
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 32 (12) , 1383-1391
Abstract
The Ministry of Health and Welfare, Japan banned coadministration of carbapenems, such as panipenem/betamipron (PAPM), meropenem (MEPM), and valproic acid (VPA) because clinical reports have indicated that the coadministration caused seizures in epileptic patients due to lowered plasma levels of VPA. In this study, we have clarified the mechanism of the drug-drug interaction using PAPM, MEPM, and doripenem [S-4661; (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-caboxylic acid monohydrate], a newly synthesized carbapenem. In vitro experiments using monkey liver slices suggested that the apparent synthetic rate of VPA glucuronide (VPA-G) increased in the presence of carbapenems. However, no such increase was observed in the experiment using monkey liver microsomes. Although no increase of uridine 5′-diphosphate d-glucuronic acid was found in monkey liver slices in the presence of carbapenems, potent inhibitory activity of carbapenems for the hydrolysis of VPA-G was found in monkey and rat liver homogenate. In vivo hydrolysis of VPA-G was clearly shown by the existence of VPA in plasma after dosing of VPA-G to rats, and its inhibition by carbapenems was also clearly shown by the negligible levels of VPA in rat plasma after coadministration of carbapenems and VPA-G. These results clearly indicate one of the important causes of drug interaction as follows: carbapenems would inhibit the hydrolytic enzyme, which is involved in the hydrolysis of VPA-G to VPA, resulting in a decrease of plasma concentration of VPA.Keywords
This publication has 12 references indexed in Scilit:
- Panipenum, A Carbapenem Antibiotic, Increases the Level of Hepatic Udp-Glucuronic Acid in RatsDrug Metabolism and Disposition, 2000
- Possible Mechanism by Which the Carbapenem Antibiotic Panipenem Decreases the Concentration of Valproic Acid in Plasma in RatsAntimicrobial Agents and Chemotherapy, 1998
- Altered Pharmacokinetics of Sodium Valproate by Simultaneous Administration with Imipenem/Cilastatin Sodium.Japanese Journal of Hospital Pharmacy, 1998
- Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipronJournal of Antimicrobial Chemotherapy, 1997
- The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: The reversible metabolism of methylprednisolone and methylprednisone in rabbitsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Biotransformation of coumarin derivatives (2). Oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and a simple assay procedure for 7-alkoxycoumarin O-dealkylase.The Japanese Journal of Pharmacology, 1983
- BIOTRANSFORMATION OF COUMARIN DERIVATIVES (2) OXIDATIVE METABOLISM OF 7-ALKOXYCOUMARIN BY MICROSOMAL ENZYMES AND A SIMPLE ASSAY PROCEDURE FOR 7-ALKOXYCOUMARIN O-DEALKYLASEThe Japanese Journal of Pharmacology, 1983
- Direct determination of UDP-glucuronic acid in cell extracts by high-performance liquid chromatographyAnalytical Biochemistry, 1982
- “Homogeneous” enzyme immunoassay. A new immunochemical techniqueBiochemical and Biophysical Research Communications, 1972
- The Isolation of Subcellular Components1959